Tempus AI(TEM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TEM Tempus AI

已收盘 07-21 16:00:00 EDT

48.98

+0.57

+1.18%

盘后49.17

+0.19+0.39%

19:59 EDT

最高50.01	最低47.74	成交量475.57万
今开48.52	昨收48.41	日振幅4.69%
总市值87.87亿	流通市值55.84亿	总股本1.79亿
成交额2.33亿	换手率4.17%	流通股本1.14亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TEM","market":"US","secType":"STK","nameCN":"Tempus AI","latestPrice":48.98,"timestamp":1784664000000,"preClose":48.41,"halted":0,"volume":4755666,"hourTrading":{"tag":"盘后","latestPrice":49.17,"preClose":48.98,"latestTime":"19:59 EDT","volume":280713,"amount":13752928.8036,"timestamp":1784678399599,"change":0.19,"changeRate":0.003879,"amplitude":0.016333},"delay":0,"changeRate":0.011774426771328245,"floatShares":113999999,"shares":179404620,"eps":-1.723147,"marketStatus":"已收盘","change":0.57,"latestTime":"07-21 16:00:00 EDT","open":48.515,"high":50.01,"low":47.74,"amount":232961482.68594,"amplitude":0.046891,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.723147,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1784707200000},"marketStatusCode":5,"adr":0,"listingDate":1718337600000,"exchange":"NASDAQ","adjPreClose":48.41,"preHourTrading":{"tag":"盘前","latestPrice":48.41,"preClose":48.41,"latestTime":"09:29 EDT","volume":115957,"amount":5673217.329174,"timestamp":1784640599999,"change":0,"changeRate":0,"amplitude":0.023218},"postHourTrading":{"tag":"盘后","latestPrice":49.17,"preClose":48.98,"latestTime":"19:59 EDT","volume":280713,"amount":13752928.8036,"timestamp":1784678399599,"change":0.19,"changeRate":0.003879,"amplitude":0.016333},"volumeRatio":0.93156,"impliedVol":0.8301,"impliedVolPercentile":0.753},"requestUrl":"/m/hq/s/TEM/wiki","defaultTab":"wiki","newsList":[{"id":"2653624208","title":"Tempus AI拟以15亿美元收购癌症检测公司Personalis","url":"https://stock-news.laohu8.com/highlight/detail?id=2653624208","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653624208?lang=zh_cn&edition=full","pubTime":"2026-07-21 09:17","pubTimestamp":1784596647,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["ARKG","BK4611","PSNL","LU1861559042.SGD","BK4613","LU1861558580.USD","TEM","TEMT","HEAL","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197746014","title":"异动解读｜Tempus AI盘中下跌6.56%，宣布15亿美元收购Personalis引发市场担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1197746014","media":"行情直击","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197746014?lang=zh_cn&edition=full","pubTime":"2026-07-20 21:36","pubTimestamp":1784554573,"startTime":"0","endTime":"0","summary":"7月20日，Tempus AI盘中下跌6.56%，报49.09美元/股，成交额5600.96万美元。消息面上，公司宣布将以每股16.25美元的价格收购Personalis，交易企业总价值达15亿美元，旨在将其分子残留病灶检测技术深度整合至AI驱动的精准肿瘤学平台。市场对此次大规模收购的资金压力及整合风险存在担忧，收购方与被收购方股价均承压。Tempus AI通过人工智能在医疗保健领域的实际应用，将实验室结果与患者临床数据连接，致力于释放精准医疗的潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652155242","title":"Tempus AI收购Personalis将分子残留病灶（MRD）深度整合进AI 精准肿瘤治疗平台本次并购结合 Pers","url":"https://stock-news.laohu8.com/highlight/detail?id=2652155242","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652155242?lang=zh_cn&edition=full","pubTime":"2026-07-20 20:39","pubTimestamp":1784551140,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1861558580.USD","BK4611","TEM","HEAL","BK4613","LU1861559042.SGD","BK4121","ARKG","TEMT","PSNL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140219481","title":"异动解读｜Tempus AI盘前下跌6.61%，宣布收购Personalis引发市场担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1140219481","media":"行情直击","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140219481?lang=zh_cn&edition=full","pubTime":"2026-07-20 20:35","pubTimestamp":1784550931,"startTime":"0","endTime":"0","summary":"7月20日，Tempus AI盘前下跌6.61%，报49.0美元/股，成交额193.81万美元。消息面上，公司宣布将以每股16.25美元的价格收购Personalis，旨在将其分子残留病灶检测技术整合至AI驱动的精准肿瘤学平台。公司表示，现金对价将动用现有现金储备及信贷额度借款。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Tempus AI收购Personalis引发市场担忧","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196410748","title":"报道称Tempus AI将以每股16.25美元的价格收购Personalis","url":"https://stock-news.laohu8.com/highlight/detail?id=1196410748","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196410748?lang=zh_cn&edition=full","pubTime":"2026-07-20 20:35","pubTimestamp":1784550902,"startTime":"0","endTime":"0","summary":"报道称医疗科技公司Tempus AI将以每股16.25美元的价格收购Personalis，受消息影响，Tempus AI 跌超6%，Personalis 盘前变化不大。","market":"us","thumbnail":"https://static.tigerbbs.com/2a3253accc7322a3db322a8557ee9834","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/2a3253accc7322a3db322a8557ee9834"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"报道称Tempus AI将以每股16.25美元的价格收购Personalis","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEMT","PSNL","TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652521307","title":"Tempus AI美股盘前跌近4%，报道称医疗科技公司Tempus AI将以每股16.25美元的价格收购Personal","url":"https://stock-news.laohu8.com/highlight/detail?id=2652521307","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652521307?lang=zh_cn&edition=full","pubTime":"2026-07-20 20:33","pubTimestamp":1784550783,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1861559042.SGD","BK4121","BK4611","ARKG","BK4613","TEM","LU1861558580.USD","TEMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158055416","title":"Tempus AI将收购Personalis，进一步整合分子残留病灶检测至其AI驱动的精准肿瘤学平台","url":"https://stock-news.laohu8.com/highlight/detail?id=1158055416","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158055416?lang=zh_cn&edition=full","pubTime":"2026-07-20 20:32","pubTimestamp":1784550720,"startTime":"0","endTime":"0","summary":"Tempus AI宣布将收购Personalis，此举旨在将其分子残留病灶检测技术更深度地整合到自身由人工智能赋能的精准肿瘤学平台之中。通过这项收购，Tempus AI计划强化其在癌症诊疗领域的数据分析与临床洞察能力，为患者提供更为个性化和动态的监测方案。整合后的平台有望提升对癌症复发风险的评估精度，助力实现更早的干预与治疗调整。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861559042.SGD","BK4121","PSNL","BK4611","HEAL","ARKG","BK4613","TEM","LU1861558580.USD","TEMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159862723","title":"Tempus AI现金对价将动用现有资金及信贷额度融资","url":"https://stock-news.laohu8.com/highlight/detail?id=1159862723","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159862723?lang=zh_cn&edition=full","pubTime":"2026-07-20 20:31","pubTimestamp":1784550704,"startTime":"0","endTime":"0","summary":"人工智能公司Tempus AI表示，其计划支付的现金对价将主要来源于公司现有现金储备，并辅以根据公司当前信贷安排所获得的借款。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","BK4613","TEM","BK4121","TEMT","LU1861559042.SGD","BK4611","HEAL","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167812788","title":"异动解读｜Tempus AI盘中下跌5.17%，合作终止及高管减持利空持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1167812788","media":"行情直击","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167812788?lang=zh_cn&edition=full","pubTime":"2026-07-17 00:23","pubTimestamp":1784219015,"startTime":"0","endTime":"0","summary":"7月17日，Tempus AI盘中下跌5.17%，报54.3美元/股，成交额1.22亿美元。近期利空因素持续发酵，股价延续弱势。消息面上，Biovica International AB此前宣布终止与Tempus AI的合作协议，明确表示双方合作未能促成产品商业化或产生任何收入。Tempus AI, Inc.通过人工智能在医疗保健领域的实际应用，致力于释放精准医疗的力量，将实验室结果与患者临床数据连接，使诊断测试更加智能化和个性化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188333358","title":"异动解读｜Tempus AI盘中上涨5.19%，报58.845美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1188333358","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188333358?lang=zh_cn&edition=full","pubTime":"2026-07-15 00:55","pubTimestamp":1784048110,"startTime":"0","endTime":"0","summary":"7月15日，Tempus AI盘中上涨5.19%，报58.845美元/股，成交额9685.74万美元。Tempus AI所在的生命科学工具和服务行业中，个股中，赛默飞世尔涨0.73%，丹纳赫跌0.42%，Illumina涨1.07%，Bio-Techne跌0.23%，沃特世涨0.81%。Tempus AI, Inc.通过人工智能在医疗保健领域的实际应用，致力于释放精准医疗的力量，将实验室结果与患者临床数据连接，使诊断测试更加智能化和个性化。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189999935","title":"异动解读｜Tempus AI盘中下跌5.05%，合作终止及高管减持持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1189999935","media":"行情直击","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189999935?lang=zh_cn&edition=full","pubTime":"2026-07-14 03:37","pubTimestamp":1783971432,"startTime":"0","endTime":"0","summary":"7月14日，Tempus AI盘中下跌5.05%，报55.285美元/股，成交额1.73亿美元。近期利空因素持续发酵，股价延续跌势。消息面上，Biovica International AB此前宣布终止与Tempus AI的合作协议，明确表示双方合作未能促成产品商业化或产生任何收入。Freedom Capital Markets近期给予公司持有评级，目标价59美元，当前股价已大幅低于该目标位。Tempus AI通过人工智能在医疗保健领域的实际应用，致力于释放精准医疗的力量，将实验室结果与患者临床数据连接，使诊断测试更加智能化和个性化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1185073062","title":"异动解读｜Tempus AI盘中下跌5.01%，合作终止及高管减持余波持续发酵","url":"https://stock-news.laohu8.com/highlight/detail?id=1185073062","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185073062?lang=zh_cn&edition=full","pubTime":"2026-07-10 22:33","pubTimestamp":1783694007,"startTime":"0","endTime":"0","summary":"7月10日，Tempus AI盘中下跌5.01%，报58.37美元/股，成交额5910.46万美元。消息面上，此前Biovica International AB宣布终止与Tempus AI的合作协议，并明确表示双方合作未能促成产品商业化上市或产生任何收入。此外，Freedom Capital Markets近期对公司启动覆盖给予持有评级，目标价59美元，当前股价已跌破该目标位，进一步加剧投资者观望态度。Tempus AI通过人工智能在医疗保健领域的实际应用，致力于释放精准医疗的力量，将实验室结果与患者临床数据连接，使诊断测试更加智能化和个性化。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650897324","title":"Tempus AI将于7月30日发布2026年第二季度财报","url":"https://stock-news.laohu8.com/highlight/detail?id=2650897324","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650897324?lang=zh_cn&edition=full","pubTime":"2026-07-09 23:41","pubTimestamp":1783611660,"startTime":"0","endTime":"0","summary":"精准医疗领域的人工智能公司Tempus AI， Inc．宣布，将于2026年7月30日（周四）美股收盘后发布截至2026年6月30日的第二季度财务业绩。公司管理层将于当天美国东部时间下午4：30召开电话会议并进行网络直播，讨论业绩表现并提供业务更新。　　近期，Freedom Capital Markets对Tempus AI启动覆盖研究，给予持有评级，目标价59美元，强调医疗健康AI是当前增长最快的科技细分领域之一，未来十年复合年增长率预计达37%至43%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-09/doc-inihftwv5225859.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ARKG","LU1861559042.SGD","BK4613","TEMT","BK4121","BK4611","HEAL","TEM","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180180371","title":"异动解读｜Tempus AI盘中上涨5.31%，报60.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1180180371","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180180371?lang=zh_cn&edition=full","pubTime":"2026-07-09 22:15","pubTimestamp":1783606552,"startTime":"0","endTime":"0","summary":"7月9日，Tempus AI盘中上涨5.31%，报60.37美元/股，成交额5283.06万美元。Tempus AI所在的生命科学工具和服务行业中，个股中，丹纳赫涨1.09%，快而精医药涨11.04%，赛默飞世尔涨0.42%，Illumina涨2.31%，Medpace Holdings涨1.07%。Tempus AI通过人工智能在医疗保健领域的实际应用，致力于释放精准医疗的力量，将实验室结果与患者临床数据连接，使诊断测试更加智能化和个性化。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194646535","title":"异动解读｜Tempus AI盘中下跌5.08%，合作伙伴终止协议称未产生任何收入","url":"https://stock-news.laohu8.com/highlight/detail?id=1194646535","media":"行情直击","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194646535?lang=zh_cn&edition=full","pubTime":"2026-07-08 23:22","pubTimestamp":1783524175,"startTime":"0","endTime":"0","summary":"7月8日，Tempus AI盘中下跌5.08%，报57.04美元/股，成交额1.11亿美元。消息面上，Biovica International AB宣布终止与Tempus AI的合作协议，并明确表示双方合作未能促成产品的商业化上市或产生任何收入。此外，公司CEO Eric P. Lefkofsky近期通过10b5-1计划减持约126,250股，成交价区间为54.82至59.59美元，高管减持叠加合作终止消息，加剧市场担忧情绪。Tempus AI通过人工智能在医疗保健领域的实际应用，致力于释放精准医疗的力量，将实验室结果与患者临床数据连接，使诊断测试更加智能化和个性化。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126040374","title":"异动解读｜Tempus AI盘前下跌5.09%，合作伙伴终止协议称未产生任何收入","url":"https://stock-news.laohu8.com/highlight/detail?id=1126040374","media":"行情直击","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126040374?lang=zh_cn&edition=full","pubTime":"2026-07-08 17:11","pubTimestamp":1783501886,"startTime":"0","endTime":"0","summary":"7月8日，Tempus AI盘前下跌5.09%，报57.03美元/股，成交额147.74万美元。消息面上，Biovica International AB宣布终止与Tempus AI的合作协议，并明确表示双方合作未能促成产品的商业化上市或产生任何收入。Tempus AI通过人工智能在医疗保健领域的实际应用，致力于释放精准医疗的力量，将实验室结果与患者临床数据连接，使诊断测试更加智能化和个性化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192729224","title":"Biovica调整美国商业战略，终止与Tempus AI的合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1192729224","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192729224?lang=zh_cn&edition=full","pubTime":"2026-07-06 15:28","pubTimestamp":1783322917,"startTime":"0","endTime":"0","summary":"Biovica International AB宣布，将重新调整其在美国的商业战略，并已终止与Tempus AI的合作协议。公司表示，与Tempus AI的合作未能促成产品的商业化上市或产生任何收入。\n此次协议的终止，不会影响Biovica位于圣地亚哥的实验室、其在美国的临床活动，以及为制药公司提供的服务业务。公司战略的调整旨在更有效地推进其核心业务在美国市场的发展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","TEM","LU1861559042.SGD","BK4121","TEMT","BK4611","LU1861558580.USD","ARKG","BK4613"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131834675","title":"Form 4 | Tempus AI, Inc. CEO兼董事长 Eric P. Lefkofsky 通过10b5-1计划合计减持126,250股Class A普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1131834675","media":"公告助手","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131834675?lang=zh_cn&edition=full","pubTime":"2026-07-02 13:51","pubTimestamp":1782971483,"startTime":"0","endTime":"0","summary":"根据最新提交的Form 4，Tempus AI, Inc.CEO兼董事长 Eric P. Lefkofsky 于2026年6月29日通过其控制的Gray Media, LLC与Blue Media, LLC在Rule 10b5-1自动计划下多次减持公司Class A普通股，合计出售约126,250股，成交价格区间为每股54.82-59.59美元。交易完成后，Gray Media, LLC和Blue Media, LLC仍分别持有约8,784,413股和15,390,469股Class A普通股，另有通过其他家族实体和基金持有的大量间接持股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Form 4 | Tempus AI, Inc. CEO兼董事长 Eric P. Lefkofsky 通过10b5-1计划合计减持126,250股Class A普通股","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100099376","title":"异动解读｜Tempus AI盘中上涨5.11%，AI医疗板块持续走强叠加多重利好催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1100099376","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100099376?lang=zh_cn&edition=full","pubTime":"2026-07-01 22:37","pubTimestamp":1782916659,"startTime":"0","endTime":"0","summary":"7月1日，Tempus AI盘中上涨5.11%，报61.46美元/股，成交额1.68亿美元。消息面上，公司近期宣布与Angiosarcoma就罕见癌症研究达成合作，进一步拓展精准医疗版图；同时美股AI医疗概念板块持续走强，资金向具备明确临床落地能力的标的集中。此外，公司此前已获FDA批准xT CDx肿瘤基因图谱检测平台（预计带来约200美元平均售价提升），并先后与施贵宝扩大战略合作、推出新一代Agentic AI药物开发平台Lens，多重利好叠加推动股价延续上行趋势。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129893301","title":"异动解读｜Tempus AI盘中上涨5.42%，AI医疗板块持续走强叠加罕见癌症合作催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1129893301","media":"行情直击","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129893301?lang=zh_cn&edition=full","pubTime":"2026-06-30 01:55","pubTimestamp":1782755718,"startTime":"0","endTime":"0","summary":"6月29日，Tempus AI盘中上涨5.42%，报59.18美元/股，成交额2.89亿美元。消息面上，公司近日宣布与Angiosarcoma就罕见癌症研究达成合作，进一步拓展其精准医疗版图。同时，美股AI医疗概念板块近期全线走强，资金从概念炒作转向场景验证，具备明确临床落地能力的标的获得持续关注。Tempus AI此前已获FDA批准xT CDx肿瘤基因图谱检测平台，并先后与施贵宝扩大战略合作、推出新一代Agentic AI药物开发平台Lens，多重利好持续释放，推动股价延续上行趋势。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tempus.com","stockEarnings":[{"period":"1week","weight":-0.1345},{"period":"1month","weight":-0.0478},{"period":"3month","weight":-0.1222},{"period":"6month","weight":-0.2589},{"period":"1year","weight":-0.2061},{"period":"ytd","weight":-0.1802}],"compareEarnings":[{"period":"1week","weight":-0.0095},{"period":"1month","weight":-0.0062},{"period":"3month","weight":0.054},{"period":"6month","weight":0.0827},{"period":"1year","weight":0.1825},{"period":"ytd","weight":0.0882}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tempus AI, Inc.由Eric Lefkofsky创立，最初于2015年8月在特拉华州以Bioin LLC的名义成立。该公司通过人工智能（AI）在医疗保健领域的实际应用，创造智能诊断，努力释放精准医疗的真正力量。他们通过将实验室结果与患者自己的临床数据连接起来，从而使测试变得智能，从而使结果个性化。","exchange":"NASDAQ","name":"Tempus AI","nameEN":"Tempus AI"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tempus AI(TEM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tempus AI(TEM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tempus AI,TEM,Tempus AI股票,Tempus AI股票老虎,Tempus AI股票老虎国际,Tempus AI行情,Tempus AI股票行情,Tempus AI股价,Tempus AI股市,Tempus AI股票价格,Tempus AI股票交易,Tempus AI股票购买,Tempus AI股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tempus AI(TEM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tempus AI(TEM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}